The Path to a new Drug
How do you develop new drugs? Here, Andreas Schamber describes the long path from research to the available drug.
High-Content Imaging on Human Pluripotent Stem Cell Research
Webinar: Professor Dr. Rafael Carazo Salas of the University of Bristol’s School of Cellular and Molecular Medicine will describe multicolor,…
High-Content Imaging on Human Pluripotent Stem Cell Research Read More »
Don’t be afraid, be bold
Read our interview with Prisca Liberali, Junior Group Leader at Friedrich Miescher Institute for Biomedical Research in Basel (Switzerland). At…
High Content Imaging for 3D Spheroid
Together with experts at InSphero and Yokogawa, we are hosting a webinar on January 14, 2021. In this webinar, we share our experience…
Yokogawa supports COVID-19 research at the Charité in Berlin
Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities actively involved in COVID-19 research. In…
Yokogawa supports COVID-19 research at the Charité in Berlin Read More »
The Future of High Content Analysis is 3D
InSphero and their pharma and biotech partners were eager to exploit the full potential of 3D models through interrogation of…
Life Science in Space
When a person thinks about Life Science usually topics like drug development, cancer research, genetic as well as 3D tissue…
The Yokogawa Life Innovation Business is on the move
In order to drive the Yokogawa Life Innovation Business (LIB) forward in Europe, Dr. Gerd Heimlich joined Yokogawa as a…
The Yokogawa Life Innovation Business is on the move Read More »
Biotechnology: Focus on Microfactories
Biotechnology enables the generation of highly complex active ingredients that are used in the treatment of, for example, diabetes. Read…